CAMP and rosacea: Rosacea patients exhibit abnormally high levels of CAMP and kallikrein-5 (KLK5), which is a serine protease that cleaves CAMP into bioactive fragments including LL-37.16 KLK5 is expressed in an inactive form that is activated on cleavage by matrix metalloproteases (MMP), including MMP9.